pennystockhaven
  • Facebook
  • Twitter
  • Youtube
  • Rss
Day-Trading Penny Stocks
  • Home
  • Services
  • Contact Us
Home» Posts tagged "Nasdaq stock market" (Page 2)

Market Overreacts on Star Scientific, Inc. (Nasdaq: CIGX)

Posted on August 26, 2011 by PennyStockHaven in Commentary, Stock Market News
Nasdaq penny stock CIGX

Shares of Star Scientific, Inc. (Nasdaq: CIGX) plunged almost 50% today on the decision issued today by the Federal Circuit Court of Appeals. Star Scientific, Inc. so far lost its patent-infringement trial against Reynolds American Inc. A few quick facts: Star Scientific has numerous valid patents, their CigRX is a proven working product, Anatabloc launch […]

Read More

Peregrine Pharmaceuticals (PPHM): Evaluation of Phase II Trials

Posted on August 24, 2011 by PennyStockHaven in Stock Market News
boipharma PPHM logo

Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported today 20.7 month median overall survival results based on Phase II study of bavituximab in combination with docetaxel in patients with metastatic breast cancer. PPHM has been traded 3 fold of its 10day average volume as of 10:15 a.m. EST Peregrine Pharmaceuticals Inc. 14282 Franklin Avenue Tustin, CA 92780 United […]

Read More

China TechFaith Wireless Communication Technology Limited (CNTF): still room to grow

Posted on August 16, 2011 by PennyStockHaven in Commentary, Stock Market News
Nasdaq penny stock CNTF

China TechFaith Wireless Communication Technology Limited (CNTF) today announced unaudited financial results for the second quarter ended June 30, 2011. Even with financials are below estimate, company has enough room to grow. Yesterday, TechFaith Wireless Technology announced that it will launch a new mobile social media solution in China called “17Talk”, along with “17Store”, through […]

Read More

Stereotaxis Inc. (STXS): Impending Bounce Play

Posted on August 9, 2011 by PennyStockHaven in Commentary, Stock Market Movers & Losers
Stereotaxis Inc. STXS logo

Stereotaxis Inc. (Nasdaq: STXS) announced Monday after-hours that its loss in the second quarter widened to $9.7 million, compared with a loss of $3.9 million in the second quarter of 2010. The St. Louis medical device maker reported revenue of $11.6 million for the quarter ended June 30, down 23 percent from $15 million a […]

Read More

OCLS & PWAV: Financial Results

Posted on August 5, 2011 by PennyStockHaven in Stock Market News
Nasdaq stock market OCLS security

Oculus Innovative Sciences, Inc. (OCLS) & Powerwave Technologies, Inc. (PWAV) today announced financial results for the last quarter. These financial achievements should have a positive impact on both stocks even with current stock market conditions. Oculus Innovative Sciences Reports Record First Quarter Financial Results PETALUMA, Calif. , Aug. 4, 2011 (GLOBE NEWSWIRE) — Oculus Innovative […]

Read More

Sun Healthcare Group Inc. (SUNH): market over-reaction on planned Medicare’s cut.

Posted on August 1, 2011 by PennyStockHaven in Commentary, Stock Market News
Nasdaq stock market penny stock SUNH

On Friday Medicare announced plan to reduce payments to skilled-nursing facilities by 11.1% for fiscal 2012, cutting $3.87 billion out of the spending plan. Sun Healthcare Group Inc. (SUNH) has been beaten down for an over 56% on this Medicare’s update. With  $75M market cap (as of today) & ~$2B in revenues Sun Healthcare Group […]

Read More

CytRx Corporation (CYTR): profiting of Nasdaq’s dilutor

Posted on July 28, 2011 by PennyStockHaven in Commentary
CYTR 2year chart

CytRx Corporation (CYTR) announced public offering of 39,200,000 shares of common stock and warrants to purchase up to 39,200,000 shares of common stock at a combined public offering price of $0.52 per share and related warrant for gross proceeds of approximately $20.4 million. CytRx’s stock has years of history of under performing based on the […]

Read More

Marshall Edwards, Inc.(MSHL): Pre-Clinical Study Announcement

Posted on July 27, 2011 by PennyStockHaven in Commentary, Stock Market Movers & Losers
Marshall Edwards MSHL

Marshall Edwards, Inc.(Nasdaq:MSHL) announced the publication of results from a pre-clinical study of its investigational compound NV-128, that’s showing activity in chemotherapy-resistant ovarian cancer stem cells. MSH stock gained over 130% on 150X 10day average volume as of 10 a.m. on July 27th. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian […]

Read More

Seven Arts Pictures PLC (SAPX): settled for multi-gains

Posted on July 25, 2011 by PennyStockHaven in Commentary
Nasdaq stock mover SAPX

Seven Arts Pictures PLC (NASDAQ:SAPX) entered into production agreement with Prodigy Pictures, Inc. to produce and distribute the highly-anticipated motion picture “Neuromancer,” based on the novel by William Gibson. As of 12:30 p.m. SAPX traded over 540K shares vs 620K free trading & settled for the multi-percentage gains in up-coming sessions. Seven Arts Pictures PLC […]

Read More

Transcept Pharmaceuticals, Inc.(Nasdaq: TSPT ): Bounce on Low Float Count

Posted on July 13, 2011 by PennyStockHaven in Commentary, Stock Market Movers & Losers
TSPT

Transcept Pharmaceuticals, Inc.(Nasdaq: TSPT ) plummeted today to a year low. Pharmaceutical company said it expects a second rejection letter from the U.S. health regulator regarding its sleep disorder drug. Transcept expects complete response letter on Intermezzo NDA Transcept Pharmaceuticals announced that it expects to receive a complete response letter from the U.S. FDA regarding […]

Read More
  • 1
  • 2
  • 3

Site

  • Home
  • Services
  • Contact Us
  • About Us
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Publishers

Financial Network

Yahoo Finance
Reuters
The Motley Fool
WSJ
CNBC
Business Week
The Street
Bloomberg

psh sloganYour Everything Penny Stocks Resource



Copyright © 2021 PennyStockHaven.com. All Rights Reserved